On The Therapeutic Potential of Tocilizumab in IL-6-Positive Cancers
Photo by ANIRUDH / Unsplash
Essays

On The Therapeutic Potential of Tocilizumab in IL-6-Positive Cancers

IL-6 is an immune signaller misappropriated by many cancer types to engender immune senescence and proliferative auto-signalling. Disrupting this misappropriation can help overcome IL-6-positive cancers.

Share this post
Digest №17: Mitochondrial Energy Generation and the Consequences of Its Aberration in Cancer
Electron microscopy image of three mitochondria, licensed from OpenOrganelle under CC BY 4.0. Sample provided by John Bernbaum and Jens H. Kuhn (NIH/NIAID/DCR/Integrated Research Facility at Fort Detrick), prepared for imaging by Song Pang (HHMI/Janelia).

Digest №17: Mitochondrial Energy Generation and the Consequences of Its Aberration in Cancer

2026, week 23: mitochondrial energy generation, alternative energy generation, and negative consequences of aberrant energy generation in cancer cells.
Digests
Merlin L. Marquard

Merlin L. Marquard